Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats

Neurogastroenterology and Motility

Volumn 27, Issue 1, 2015, Pages 30-39

  Su, J ^a   Tanaka, Y ^a   Muratsubaki, T ^a   Kano, M ^a   Kanazawa, M ^a   Fukudo, S ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain gut interaction; Central amygdaloid nucleus; CRD; Dopamine; Noradrenaline; Serotonin

Indexed keywords

CORTICOTROPIN-RELEASING HORMONE; CP 154526; DOPAMINE; NOREPINEPHRINE; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEROTONIN;

AMYGDALA; ANIMALS; ANTAGONISTS AND INHIBITORS; COLON; DILATATION, PATHOLOGIC; DRUG EFFECTS; MALE; NOCICEPTION; PATHOLOGY; PHYSIOLOGY; RATS; RATS, WISTAR; RECTUM; SECRETION;

AMYGDALA; ANIMALS; COLON; CORTICOTROPIN-RELEASING HORMONE; DILATATION, PATHOLOGIC; DOPAMINE; MALE; NOCICEPTION; NOREPINEPHRINE; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECTUM; SEROTONIN;

EID: 84920084069     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12462     Document Type: Article

References (66)

1. Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol 1993; 17: 133-41.
2. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998; 42: 845-9.
3. Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage 2009; 47: 946-51.
4. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-90.
5. Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 2001; 62(Suppl. 8): 28-36; discussion 37.
6. Fukudo S. IBS: autonomic dysregulation in IBS. Nat Rev Gastroenterol Hepatol 2013; 10: 569-71.
7. Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, Verrier P, Poitras P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 1771-7.
8. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
9. Kumar D, Wingate DL. The irritable bowel syndrome: a paroxysmal motor disorder. Lancet 1985; 2: 973-7.
10. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monitor 2004; 10: Ra55-62.
11. Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD. Functional GI disorders: from animal models to drug development. Gut 2008; 57: 384-404.
12. Gue M, Tekamp A, Tabis N, Junien JL, Bueno L. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala. Brain Res 1994; 658: 232-8.
13. LeDoux JE, Iwata J, Cicchetti P, Reis DJ. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988; 8: 2517-29.
14. Lyubashina OA. Possible mechanisms of involvement of the amygdaloid complex in the control of gastric motor function. Neurosci Behav Physiol 2004; 34: 379-88.
15. Rostad H. Colonic motility in the cat. V. Influence of telencephalic stimulation and the peripheral pathways mediating the effects. Acta Physiol Scand 1973; 89: 169-81.
16. Schwaber JS, Kapp BS, Higgins GA, Rapp PR. Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus. J Neurosci 1982; 2: 1424-38.
17. Cassell MD, Gray TS, Kiss JZ. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J Comp Neurol 1986; 246: 478-99.
18. Gray TS. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci 1993; 697: 53-60.
19. Steckler T, Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 1999; 46: 1480-508.
20. Tache Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001; 280: G173-7.
21. Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007; 117: 33-40.
22. Bernard JF, Huang GF, Besson JM. The parabrachial area: electrophysiological evidence for an involvement in visceral nociceptive processes. J Neurophysiol 1994; 71: 1646-60.
23. Gauriau C, Bernard JF. Pain pathways and parabrachial circuits in the rat. Exp Physiol 2002; 87: 251-8.
24. Traub RJ, Silva E, Gebhart GF, Solodkin A. Noxious colorectal distention induced-c-Fos protein in limbic brain structures in the rat. Neurosci Lett 1996; 215: 165-8.
25. Harris JA. Using c-fos as a neural marker of pain. Brain Res Bull 1998; 45: 1-8.
26. Butler PD, Weiss JM, Stout JC, Nemeroff CB. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 1990; 10: 176-83.
27. Finlay JM, Zigmond MJ. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res 1997; 22: 1387-94.
28. Petrov T, Krukoff TL, Jhamandas JH. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 1994; 277: 289-95.
29. Koeglermuly SM, Owens MJ, Ervin GN, Kilts CD, Nemeroff CB. Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 1993; 5: 95-8.
30. Kalivas PW, Duffy P, Latimer LG. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 1987; 242: 757-63.
31. Kosoyan HP, Grigoriadis DE, Tache Y. The CRF(1) receptor antagonist, NBI-35965, abolished the activation of locus coeruleus neurons induced by colorectal distension and intracisternal CRF in rats. Brain Res 2005; 1056: 85-96.
32. Saito K, Kanazawa M, Fukudo S. Colorectal distention induces hippocampal noradrenaline release in rats: an in vivo microdialysis study. Brain Res 2002; 947: 146-9.
33. Goldstein LE, Rasmusson AM, Bunney BS, Roth RH. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 1996; 16: 4787-98.
34. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999; 13(Suppl. 2): 15-30.
35. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000; 95: 2698-709.
36. Lavicky J, Dunn AJ. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 1993; 60: 602-12.
37. Wanat MJ, Hopf FW, Stuber GD, Phillips PEM, Bonci A. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of I-h. J Physiol-London 2008; 586: 2157-70.
38. Muramatsu T, Inoue K, Iwasaki S, Yamauchi T, Hayashi T, Kiriike N. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats. Pharmacol Biochem Behav 2006; 85: 435-40.
39. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res 1988; 450: 153-69.
40. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates (4th). New York: Academic, 1998.
41. Saito K, Kasai T, Nagura Y, Ito H, Kanazawa M, Fukudo S. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats. Gastroenterology 2005; 129: 1533-43.
42. Johnson AC, Tran L, Schulkin J. Greenwood-Van Meerveld B. Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Neurogastroenterol Motil 2012; 24: 479-86, e219.
43. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 2005; 17: 415-22.
44. Saito-Nakaya K, Hasegawa R, Nagura Y, Ito H, Fukudo S. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol Motil 2008; 20: 1147-56.
45. Kim SH, Han JE, Hwang S, Oh DH. The expression of corticotropin-releasing factor in the central nucleus of the amygdala, induced by colorectal distension, is attenuated by general anesthesia. J Korean Med Sci 2010; 25: 1646-51.
46. Monnikes H, Schmidt BG, Tebbe J, Bauer C, Tache Y. icroinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Res 1994; 644: 101-8.
47. Lazovic J, Wrzos HF, Yang QX, Collins CM, Smith MB, Norgren R, Matyas K, Ouyang A. Regional activation in the rat brain during visceral stimulation detected by c-fos expression and fMRI. Neurogastroent Motil 2005; 17: 548-56.
48. Ciccocioppo R, de Guglielmo G, Hansson AC, Ubaldi M, Kallupi M, Cruz MT, Oleata CS, Heilig M et al. Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors. J Neurosci 2014; 34: 363-72.
49. Myers DA, Gibson M, Schulkin J, Greenwood Van-Meerveld B. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav Brain Res 2005; 161: 39-44.
50. Hubbard CS, Labus JS, Bueller J, Stains J, Suyenobu B, Dukes GE, Kelleher DL, Tillisch K et al. Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. J Neurosci 2011; 31: 12491-500.
51. Retson TA, Van Bockstaele EJ. Coordinate regulation of noradrenergic and serotonergic brain regions by amygdalar neurons. J Chem Neuroanat 2013; 52: 9-19.
52. Lechner SM, Curtis AL, Brons R, Valentino RJ. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997; 756: 114-24.
53. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990; 15: 71-100.
54. Liang KC, Melia KR, Miserendino MJD, Falls WA, Campeau S, Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci 1992; 12: 2303-12.
55. Cabib S, Kempf E, Schleef C, Oliverio A, Puglisiallegra S. Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration. Brain Res 1988; 441: 153-60.
56. Herman JP, Guillonneau D, Dantzer R, Scatton B, Semerdjianrouquier L, Lemoal M. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci 1982; 30: 2207-14.
57. Gurkovskaya OV, Palamarchouk V, Smagin G, Goeders NE. Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats. Synapse 2005; 57: 202-12.
58. Ide S, Hara T, Ohno A, Tamano R, Koseki K, Naka T, Maruyama C, Kaneda K et al. Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats. J Neurosci 2013; 33: 5881-94.
59. Tan KR, Yvon C, Turiault M, Mirzabekov JJ, Doehner J, Labouebe G, Deisseroth K, Tye KM et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 2012; 73: 1173-83.
60. Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, Dedic N, Schumacher M et al. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 2011; 333: 1903-7.
61. Ray A, Henke PG, Sullivan RM. Effects of intra-amygdalar dopamine agonists and antagonists on gastric stress lesions in rats. Neurosci Lett 1988; 84: 302-6.
62. Forster GL, Feng N, Watt MJ, Korzan WJ, Mouw NJ, Summers CH, Renner KJ. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 2006; 141: 1047-55.
63. Asan E, Steinke M, Lesch KP. Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety. Histochem Cell Biol 2013; 139: 785-813.
64. Price ML, Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 2001; 21: 2833-41.
65. Homberg JR, Contet C. Deciphering the interaction of the corticotropin-releasing factor and serotonin brain systems in anxiety-related disorders. J Neurosci 2009; 29: 13743-5.
66. Taché Y, Million M, Nelson AG, Lamy C, Wang L. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med 2005; 2: 146-54.